{"id":"https://openalex.org/W4310163326","doi":"https://doi.org/10.1182/blood-2022-169117","title":"Flap Structure-Specific Endonuclease 1 Coordinates with a Helicase (ASCC3) to Drive Genomic Instability, Proliferation and Poor Clinical Outcome in Myeloma","display_name":"Flap Structure-Specific Endonuclease 1 Coordinates with a Helicase (ASCC3) to Drive Genomic Instability, Proliferation and Poor Clinical Outcome in Myeloma","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310163326","doi":"https://doi.org/10.1182/blood-2022-169117"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-169117","doi":"https://doi.org/10.1182/blood-2022-169117","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-169117","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084310044","display_name":"Chengcheng Liao","orcid":"https://orcid.org/0000-0003-0408-6684","observed_orcids":["https://orcid.org/0000-0003-0408-6684"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chengcheng Liao","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112389374","display_name":"Srikanth Talluri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srikanth Talluri","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058738548","display_name":"Shidai Mu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shidai Mu","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103420970","display_name":"Subodh Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Subodh Kumar","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078948384","display_name":"Lakshmi B. Potluri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lakshmi B. Potluri","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027257617","display_name":"Jialan Shi","orcid":"https://orcid.org/0000-0001-5642-5436","observed_orcids":["https://orcid.org/0000-0001-5642-5436"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jialan Shi","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036264384","display_name":"Leutz Buon","orcid":"https://orcid.org/0009-0000-5990-1936","observed_orcids":["https://orcid.org/0009-0000-5990-1936"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leutz Buon","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masood A. Shammas","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C Munshi","raw_affiliation_strings":["2Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA","3VA Boston Healthcare System, Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"3VA Boston Healthcare System, Boston,","institution_ids":["https://openalex.org/I2801671727"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"140","issue":"Supplement 1","first_page":"9963","last_page":"9963"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.03420000150799751,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11369","display_name":"Genetic factors in colorectal cancer","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fen1","display_name":"FEN1","score":0.8799999952316284},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.722000002861023},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.9850000143051147},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.8640000224113464},{"id":"https://openalex.org/keywords/dna-helicase","display_name":"DNA helicase","score":0.8379999995231628},{"id":"https://openalex.org/keywords/dna-replication","display_name":"DNA replication","score":0.8650000095367432},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.5669999718666077},{"id":"https://openalex.org/keywords/protein-protein-interaction","display_name":"protein-protein interaction","score":0.8029999732971191},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.6830000281333923},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.7379999756813049},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.5400000214576721},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6520000100135803},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.367000013589859},{"id":"https://openalex.org/keywords/fibroblasts","display_name":"fibroblasts","score":0.7070000171661377},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.3409999907016754},{"id":"https://openalex.org/keywords/metabolic-pathways","display_name":"metabolic pathways","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.8200839757919312},{"id":"https://openalex.org/C73573662","wikidata":"https://www.wikidata.org/wiki/Q130996","display_name":"DNA replication","level":3,"score":0.6622347831726074},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.660671591758728},{"id":"https://openalex.org/C161223559","wikidata":"https://www.wikidata.org/wiki/Q138864","display_name":"Helicase","level":4,"score":0.6568120121955872},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6230624318122864},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.6136494874954224},{"id":"https://openalex.org/C2780751114","wikidata":"https://www.wikidata.org/wiki/Q7302254","display_name":"RecQ helicase","level":5,"score":0.5562741160392761},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.48123693466186523},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.47894126176834106},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4770074188709259},{"id":"https://openalex.org/C34688535","wikidata":"https://www.wikidata.org/wiki/Q418732","display_name":"Proliferating cell nuclear antigen","level":3,"score":0.4540163278579712},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.4244233965873718},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3961372971534729},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3837432563304901},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.33580291271209717},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.19176897406578064},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.18969020247459412},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.15545183420181274}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-169117","doi":"https://doi.org/10.1182/blood-2022-169117","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-169117","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3213113450","https://openalex.org/W2802409103","https://openalex.org/W2979529933","https://openalex.org/W2021483139","https://openalex.org/W3168109303","https://openalex.org/W2648902637","https://openalex.org/W2058553466","https://openalex.org/W1997403157","https://openalex.org/W2991555758","https://openalex.org/W2005448675"],"abstract_inverted_index":{"Genomic":[0],"instability":[1,95,272,441],"leads":[2],"to":[3,18,190,257,447,456],"an":[4,31],"increased":[5,67,240,289],"frequency":[6],"of":[7,34,40,79,88,120,155,199,214,222,233,287,293,306,350,368,461],"aberrations":[8],"at":[9,322],"the":[10,76,118,149,203,211,220,231,285,290,304,314,338,351,356,365,454,462],"single":[11],"nucleotide":[12],"and":[13,21,50,75,96,125,133,159,165,202,219,253,266,270,358,371,401,420,435,442,466],"chromosomal":[14],"levels,":[15],"thus":[16,445],"contributing":[17,446],"cancer":[19,43,104],"progression":[20],"poor":[22,375,448],"clinical":[23,449],"outcomes.":[24],"We":[25],"have":[26],"previously":[27],"reported":[28],"FEN1":[29,41,64,89,112,150,189,207,288,370,397,409],"as":[30,175,177,275,277],"important":[32],"driver":[33],"genomic":[35,51,94,271,440],"evolution":[36],"in":[37,42,56,90,102,114,140,192,235,248,273,308,317,328,337,355,378,473],"MM.":[38],"Suppression":[39],"cells":[44,58,92,239,330,465],"inhibits":[45,107],"DNA":[46,68,121,126,156,166,178,216,241],"breaks,":[47],"HR":[48,174,268],"activity":[49,170,269],"instability,":[52],"whereas":[53,99,130,245,284,342],"its":[54,100,223,246],"overexpression":[55,65,87,113,232,286],"non-cancerous":[57,80,115],"increases":[59,93],"those":[60],"activities.":[61,110],"In":[62],"addition,":[63],"also":[66,263],"replication":[69,127,242],"(as":[70],"assessed":[71],"by":[72,243],"BrdU":[73],"labeling)":[74],"growth":[77,291,318],"rate":[78,292],"cells.":[81,360],"Here,":[82],"we":[83,180,209],"further":[84,392,411,457],"demonstrate":[85],"that":[86,148,182,429],"normal":[91,236],"cell":[97,105,116,143,250,281,295,311,340,353,443],"growth,":[98],"suppression":[101],"a":[103,185,215,258,334,347,432,436],"line":[106],"these":[108,194,363],"functional":[109,212],"During":[111],"types,":[117],"pathways":[119,135],"repair":[122,160],"(especially":[123],"HR)":[124],"were":[128,136],"upregulated,":[129],"several":[131,163],"metabolic":[132],"apoptosis":[134],"downregulated.":[137],"Mass":[138],"spectrometry":[139,205],"two":[141],"MM":[142,249,274,294,310,464],"lines":[144,251,296,312],"(MM1S,":[145,297],"RPMI8226)":[146],"revealed":[147],"interactome":[151],"was":[152,331,344],"mainly":[153],"comprised":[154],"damage":[157],"response":[158],"proteins,":[161],"including":[162],"RNA":[164],"helicases.":[167],"Since":[168],"helicase":[169,186,217],"is":[171],"required":[172],"for":[173,229,469],"well":[176,276],"replication,":[179],"hypothesized":[181],"interaction":[183,224,430],"with":[184,206,225,333,346,362,374,395,414],"may":[187],"enable":[188],"participate":[191],"both":[193,369],"processes.":[195],"Based":[196],"on":[197],"analysis":[198],"RNA-seq":[200],"data":[201,427,452],"mass":[204],"immuno-precipitate,":[208],"investigated":[210],"significance":[213],"(ASCC3)":[218],"importance":[221],"FEN1.":[226],"As":[227],"observed":[228],"FEN1,":[230,438],"ASCC3":[234,261,299,307,372,390,416],"human":[237],"fibroblast":[238],"~2-fold,":[244],"knockdown":[247,262,300,305],"(H929":[252],"JJN3)":[254],"reduced":[255,301],"it":[256],"similar":[259],"extent.":[260],"inhibited":[264],"spontaneous":[265],"FEN1-induced":[267],"other":[278],"solid":[279],"tumor":[280],"types.":[282],"Consistently,":[283],"H929),":[298],"it.":[302],"Importantly,":[303],"FEN1-overexpressing":[309,359],"prevented":[313],"FEN1-mediated":[315],"increase":[316,336],"rate.":[319],"For":[320],"example,":[321],"day":[323],"5":[324],"after":[325],"selection,":[326],"FEN1-overexpression":[327],"H929":[329],"associated":[332,345],"\u223c50%":[335],"viable":[339,352],"fraction,":[341],"ASCC3-knockdown":[343],"complete":[348],"loss":[349],"fraction":[354],"control":[357],"Consistent":[361],"observations,":[364],"high":[366,389,396,408,415],"expression":[367,391,398,410,417],"correlated":[373],"overall":[376],"survival":[377],"myeloma":[379],"patients":[380,394,413],"(in":[381],"MMRF":[382],"patient":[383],"dataset;":[384],"p":[385],"<":[386],"0.008).":[387],"Furthermore,":[388],"separated":[393,412],"into":[399,418],"high-":[400,419],"low-risk":[402,421],"categories":[403,422],"(p":[404,423],"=":[405,424],"0.025).":[406],"Similarly,":[407],"0.00025).":[425],"These":[426,451],"suggest":[428],"between":[431],"helicase,":[433],"ASCC3,":[434],"nuclease,":[437],"drives":[439],"proliferation":[444],"outcome.":[450],"provide":[453],"basis":[455],"study":[458],"molecular":[459,467],"characteristics":[460],"high-risk":[463,474],"targets":[468],"therapeutic":[470],"consideration,":[471],"especially":[472],"patients.":[475]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-11-30T00:00:00"}